| Current Price | $90.22 | Mkt Cap | $16.6B |
|---|---|---|---|
| Open | $87.61 | P/E Ratio | 1,033.44 |
| Prev. Close | $90.22 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $86.40 - $90.32 | Volume | 1,349,566 |
| 52-Wk Range | $71.59 - $92.17 | Avg. Daily Vol. | 1,484,455 |
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
| Current Price | $90.22 | Mkt Cap | $16.6B |
|---|---|---|---|
| Open | $87.61 | P/E Ratio | 1,033.44 |
| Prev. Close | $90.22 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $86.40 - $90.32 | Volume | 1,349,566 |
| 52-Wk Range | $71.59 - $92.17 | Avg. Daily Vol. | 1,484,455 |
The best Bull and Bear pitches based on recency and number of recommendations.
The global target market for Morquio syndrome patients with ability to pay for treatment is around 2500 patients. ThinkEquity analyst Kimberly Lee estimates the market potential of GALNS at 575 million annually. This would be $230,000 annually per… More
Read the most recent pitches from players about BMRN.
Recs
Investor008
(< 20)
Submitted: 11/5/2021 12:15:08 PM :
Start Price:
$83.98
NASDAQ:BMRN Score:
+7.97
A good biotech stock
Recs
CMFMLove
(55.47)
Submitted: 10/28/2021 1:02:45 PM :
Start Price:
$75.85
NASDAQ:BMRN Score:
+16.89
New pipeline will double revenues.
Recs
StingyHobo
(< 20)
Submitted: 1/24/2021 7:58:41 PM :
Start Price:
$85.86
NASDAQ:BMRN Score:
-16.40
From basic research it appears that this is a healthy company that has high value products that will be on the market soon. The only reason their valuation sank so low is because one of their anticipated drugs got delayed on approval. First, the company can thrive without that product. Second, the product was not rejected but delayed. Upon approval this company should once again skyrocket.
Find the members with the highest scoring picks in BMRN.
Jmcq88 (90.53) Score: +758.20
The Score Leader is the player with the highest score across all their picks in BMRN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| BreakerBeth | 96.12 | 5/17/2006 |
|
5Y | $12.26 | +633.46% | +287.21% | +346.25 | 1 Comment | |
| RBBioContest06 | 37.63 | 6/1/2006 |
|
1Y | $13.05 | +589.06% | +290.62% | +298.44 | 1 Comment | |
| DamYankee | < 20 | 9/29/2006 |
|
1Y | $14.41 | +524.03% | +268.75% | +255.27 | 0 Comment | |
| MellieMel777 | 42.51 | 9/29/2006 |
|
3Y | $14.41 | +524.03% | +268.75% | +255.27 | 1 Comment | |
| taxisvs | 48.72 | 10/2/2006 |
|
NS | $15.00 | +499.48% | +269.46% | +230.02 | 0 Comment | |
| rolloro | < 20 | 10/2/2006 |
|
3Y | $15.00 | +499.48% | +269.46% | +230.02 | 1 Comment | |
| mgaal | < 20 | 4/30/2007 |
|
1Y | $16.16 | +456.45% | +228.33% | +228.12 | 0 Comment | |
| phytoremediation | < 20 | 4/30/2007 |
|
3M | $16.16 | +456.45% | +228.33% | +228.12 | 1 Comment | |
| inthefield | 80.99 | 4/30/2007 |
|
NS | $16.16 | +456.45% | +228.33% | +228.12 | 0 Comment | |
| ggkeith | < 20 | 9/23/2006 |
|
5Y | $15.06 | +497.09% | +275.85% | +221.24 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
